Edition:
United States

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

2.28USD
20 Apr 2018
Change (% chg)

$0.03 (+1.33%)
Prev Close
$2.25
Open
$2.28
Day's High
$2.28
Day's Low
$2.28
Volume
1,085
Avg. Vol
43,054
52-wk High
$5.99
52-wk Low
$1.64

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: 0.64
Market Cap(Mil.): $6.75
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  ORPN.OQ Industry Sector
P/E (TTM): -- 185.16 33.25
EPS (TTM): -2.57 -- --
ROI: -111.78 -0.71 13.13
ROE: -111.78 -2.76 14.96

BRIEF-Bioblast Pharma reports Q3 loss per share $0.32

* Bioblast Pharma reports third quarter 2017 financial results

Nov 02 2017

Earnings vs. Estimates